Cite
HARVARD Citation
Liu, D. et al. (2016). CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas. CNS neuroscience & therapeutics. pp. 518-524. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liu, D. et al. (2016). CAMKK2, Regulated by Promoter Methylation, is a Prognostic Marker in Diffuse Gliomas. CNS neuroscience & therapeutics. pp. 518-524. [Online].